| Literature DB >> 31402656 |
Laura Sánchez-Rivera1, Pedro Ferreira Santos2, M Angeles Sevilla2,3, M José Montero2,3, Isidra Recio1, Beatriz Miralles1.
Abstract
The antihypertensive activity of two αs1-casein-derived peptides and casein hydrolysate containing these sequences was evaluated in the presence of naloxone. The activity was abolished by this opioid antagonist at 2, 4, and 6 h post-administration. Similarly, the antihypertensive effect of the αs1-casein peptides 90RYLGY94 (-23.8 ± 2.5 mmHg) and 143AYFYPEL149 (-21.1 ± 3.2 mmHg) at 5 mg/kg of body weight was antagonized by the co-administration of naloxone. Because peptide 143AYFYPEL149 had recently shown opioid activity, a molecular dynamic simulation of this peptide with human μ-opioid receptor was performed to demonstrate its favorable structure and interaction energy, despite the presence of Ala at the N terminus. Altogether, these results revealed that the in vivo effect on systolic blood pressure of the studied αs1-casein peptides is mediated by interaction with opioid receptors and the antihypertensive activity of casein hydrolysate can be very likely ascribed to them with the possible contribution of other mechanisms.Entities:
Keywords: antihypertensive peptide; casein hydrolysate; naloxone; opioid receptor; spontaneously hypertensive rat
Mesh:
Substances:
Year: 2019 PMID: 31402656 DOI: 10.1021/acs.jafc.9b03872
Source DB: PubMed Journal: J Agric Food Chem ISSN: 0021-8561 Impact factor: 5.279